Edesa Biotech, Inc. (EDSA)

Edesa Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Year	2023	2022	2021	2020	2018
Net Income	-8.37	-17.55	-13.34	-6.36	-1.87
Depreciation & Amortization	0.18	0.12	0.12	0.06	0
Share-Based Compensation	1.25	2.26	3.2	0.6	0.08
Other Operating Activities	0.31	2.89	-3.64	0.72	0.49
Operating Cash Flow	-6.64	-12.28	-13.66	-4.99	-1.29
Capital Expenditures	0	-0.01	-0.01	0.05	-0.01
Other Investing Activities	-	-	-	-0.03	-
Investing Cash Flow	0	-0.01	-0.01	0.02	-0.01
Share Issuance / Repurchase	4.83	11.63	14.17	7.12	0
Debt Issued / Paid	0	0	0	0.03	0
Other Financing Activities	-	-	-	-0.06	-
Financing Cash Flow	4.83	11.63	14.17	7.09	0
Exchange Rate Effect	0.08	-0.09	0.12	0.06	-0.34
Net Cash Flow	-1.73	-0.75	0.63	2.18	-1.63
Free Cash Flow	-6.64	-12.28	-13.67	-4.94	-1.3
Free Cash Flow Margin	-	-	-	-1501.75%	-
Free Cash Flow Per Share	-2.32	-5.86	-7.92	-4.02	-2.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).